Website Navigation

EORTC Qlq Lc13

Results for EORTC Qlq Lc13:
 Also try:
 Ads:
  1. EORTC QLQ - LC13 - Welcome to the EORTC Groups Websites

    ENGLISH EORTC QLQ - LC13 Patients sometimes report that they have the following symptoms or problems. Please indicate the extent to which you have experienced …

    groups.eortc.be/qol/sites/default/files/img/specimen_lc13_english.pdf
  1. PoCoG - The EORTC HRQoL measurement suite

    The EORTC QLQ-C30 has undergone a number of revisions since its inception as the QLQ-C36 in 1986. Subsequently modified to improve its psychometric properties and ...

    www.pocog.org.au/content.aspx?page=EORTC
  1. EORTC QLQ-C30 Download Selection

    Language QLQ-C30 Core Lung LC13 Breast BR23 Head & Neck H&N35 Ovarian OV28 O181eesophageal OES18 Gastric STO22 Cervix CX24 Myeloma MY20 Oesophago-Gastric …

    www.eortc.be/qol/downloads/QLQC30/select.asp
  1. European Organization for the Research and Treatment of ...

    European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire and Lung Cancer Module (QLQ-LC13) Name of Questionnaire

    qol.thoracic.org/sections/instruments/ae/pages/qlq-lc13.html
  1. EORTC QLQ-C30 Reference Values - Welcome to the EORTC ...

    EORTC QLQ-C30 Reference Values This manual presents reference data for the QLQ-C30 based upon data provided by EORTC Quality of Life Group Members and other users

    groups.eortc.be/qol/sites/default/files/img/newsletter/reference...
  1. European Organization for the Research and Treatment of ...

    European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) Name of Questionnaire. European Organization for …

    qol.thoracic.org/sections/instruments/ae/pages/qlq-c30.html
  1. A multicentre phase II study of cisplatin and gemcitabine ...

    Our previous phase II study of cisplatin and gemcitabine in malignant mesothelioma showed a 47.6% (95% CI 26.2–69.0%) response rate with symptom improvement in ...

    www.ncbi.nlm.nih.gov › NCBI › Literature
  1. Lung cancer Review FINAL112010 - University of Oxford

    patient-reported outcome measurement group, oxford a structured review of patient-reported outcome measures (proms) for lung cancer report to the department of

    phi.uhce.ox.ac.uk/pdf/CancerReviews/PROMs_Oxford_Lung%20Cancer...
  1. 국립암센터

    주의사항. eortc-qlq 평가도구 중 현재 이용가능한 평가도구(c30, lc13, br23, st22,)를 사용하고자 할 때에는 eortc qol group의 인터넷 ...

    www.ncc.re.kr/sri/manage/manage05/content_3341.jsp
  1. Phase II AZD9291 Open Label Study in NSCLC After Previous ...

    Phase II AZD9291 Open Label Study in NSCLC After Previous EGFR TKI Therapy in EGFR and T790M Mutation Positive Tumours (AURA2)

    clinicaltrials.gov › Home › Find Studies
Also try:
 Ads: